| Financial Year |
March 31 2023 |
| Monetary Funds |
32,921,406,958.83 |
| Held-for-trading Financial Assets |
84,273,528.37 |
| Notes Receivable |
-- |
| Accounts Receivable |
503,957,903.87 |
| Advances to Suppliers |
4,285,769.88 |
| Other Receivables |
35,069,457,825.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
192,019,239,147.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,542,241,831.21 |
| Total Current Assets |
273,144,862,965.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,457,418,390.82 |
| Investment Properties |
6,833,734,517.82 |
| Fixed Assetes |
569,222,988.12 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
135,178,070.34 |
| R&D expenses |
-- |
| Goodwill |
593,092.34 |
| Long-Term Deferred and Prepaid Expenses |
49,686,342.24 |
| Deferred Income Tax Assets |
1,772,559,701.97 |
| Other Non-Current Assets |
2,617,078.53 |
| Sub-Total of Non-Current Assets |
25,837,333,231.04 |
| Total Assets |
298,982,196,196.43 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,461,773,262.77 |
| Accounts Received In Advance |
44,675,085.50 |
| Employee Compensation Payable |
15,040,921.67 |
| Taxes Payable |
762,924,394.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,722,268,290.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,541,574,402.42 |
| Other Current Liabilities |
14,952,509,304.06 |
| Sub-Total of Current Liabilities |
200,274,863,251.99 |
| Long-term Loans |
38,108,763,886.09 |
| Bonds Payable |
2,029,565,907.33 |
| Long-Term Accounts Payable |
567,819,229.01 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
126,545,312.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,929,714,858.74 |
| Total Liabilities |
241,204,578,110.73 |
| Paid-In Capital(Or Share Stock) |
3,111,443,890.00 |
| Capital Surplus |
2,095,116,827.09 |
| Surplus Reserve |
1,516,302,211.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
17,592,134,343.15 |
| Minority Stockholder's Interest |
33,688,063,012.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,089,555,072.77 |
| Owner's Equity（Stockholder's Equity） |
57,777,618,085.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
298,982,196,196.43 |
